Beat Childhood Cancer offers phase I and phase II clinical trials to children battling childhood cancer. Our focus is on using precision medicine in patients at diagnosis as well as in difficult-to-treat relapsed and refractory cancers. Our goal is to increase survival and decrease toxicity while targeting the unique factors driving each child’s tumor.